This contract expires in 258 days (Dec 31, 2026).
FIRM FIXED PRICE
NOVARTIS PHARMACEUTICALS CORPORATION - RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS
PIID: 36C24426F0063
Signed Date: Dec 19, 2025Effective Date: Jan 1, 2026End Date: Closes in 258 days
Key Details
Description
RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS
Contractor Information
Contractor: NOVARTIS PHARMACEUTICALS CORPORATION
UEI: NG61ZA8TADW3
CAGE Code: 04520
Location: EAST HANOVER, NJ
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.